• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » BD touts cybersecurity cred of its microbiology informatics software

BD touts cybersecurity cred of its microbiology informatics software

February 21, 2020 By Sean Whooley

Becton DickinsonBecton Dickinson (NYSE:BDX) announced that its BD Synapsys microbiology informatics solution received certification from the Underwriters Laboratory Cybersecurity Assurance Program (UL CAP).

UL CAP is an independent program that uses standardized, testable criteria to assess software vulnerabilities and weaknesses. BD touts its BD Synapsys software as one of the first life-science diagnostics informatics platforms to meet all UL CAP cybersecurity standards.

“Cybersecurity is top of mind for our customers,” BD president of life sciences – integrated diagnostic solutions Dave Hickey said in a news release. “Securing connected solutions is essential to patient safety and privacy. By being among the first in the diagnostics space to receive UL CAP certification for an informatics platform, BD is demonstrating its ongoing commitment to taking a proactive approach to cybersecurity.”

BD Synapsys is a browser-based informatics solution designed to offer laboratories connectivity for BD diagnostics instruments, rules-based workflow management tools, tools for streamlining communication and on-demand insights to improve performance.

According to the news release, a cybersecurity breach of a platform like BD Synapsys could create a risk to privacy and patient safety as it comprises a key part of the diagnostic process.

Dr. Chuck Cooper, BD’s VP of medical & scientific affairs in integrated diagnostic solutions, said a cyber breach could compromise patients due to interruptions in the reporting of results, while concerns about accuracy and authenticity could create confusion.

“There is little to no room for this kind of disruption in the care of patients with life-threatening conditions,” Cooper said in the release.

BD said earning UL CAP certification for its BD Synapsys platform is part of an ongoing strategy for the company to partner with government and industry leaders as it looks to enhance its cybersecurity efforts.

“We are very pleased to see BD leading the way to help ensure the safety and security of critical laboratory data,” UL’s chief innovation architect for medical systems interoperability & security Anura Fernando said in the release. “The importance to clinicians and patients alike of protecting the privacy and security of sensitive health-oriented information cannot be overstated.”

Filed Under: Digital Health, Health Information Technology, Health Technology, Patient Monitoring, Software / IT Tagged With: becton dickinson, Cybersecurity, Underwriter's Laboratories

More recent news

  • Neuronetics names Steven Pfanstiel chief financial officer
  • Medtronic to distribute Future Medical’s peripheral guidewires
  • AtriCure completes enrollment in stroke prevention trial
  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy